Mission Statement

To be the leader in development, manufacturing and commercialization of affordable Medical Devices for India, emerging markets and developing countries.

Relisys Medical Devices Limited is leading manufacturer in Cardiovascular Medical Devices like Coronary Stents Systems including both Bare Metal Stent System & Drug Eluting Stent Systems, PTCA Balloons Catheters, Angiographic Diagnostic Catheters and Guiding Catheters. Relisys is involved in development, manufacturing and commercialization of these affordable Medical Devices to treat life-threatening heart diseases.

Relisys is founded and promoted by leading technocrats and clinicians. The purpose of Relisys is to provide life saving devices which delivers performance and safety with affordability. With the primary focus on clinical outcome of devices, Relisys’ products are reliable and very well accepted across the market.

Relisys is only facility in India with integrated development & manufacturing capability of Stents, Stent Delivery Systems, PTCA Balloon catheters, Guiding Catheters and Angiographic Diagnostic Catheters (Femoral & Radial). The facility is spread over 1,60,000 sqft. and 35,000 sqft class 10K clean rooms. Relisys is EN ISO 13485: 2016 certified and recognized by DSIR. It is recognized by the Department of Science and Technology- India. The strong R&D backbone and precisely followed manufacturing operations for various process of manufacturing like Stent Cutting (Laser), Post Cutting Electro Mechanical and Chemical Processing, Extrusion, Braiding, PTCA Catheter- Balloon Blowing, Assembly /Laser Welding, Stent Crimping, Drug Coating and Characterization, Pharmacokinetics among others are the factors for Relisys’ best quality devices.

With 100% vertically integrated facility, various available technology platforms that which work beyond Cardiovascular industry, strong R&D team and quest to venture into other domains of Medical Devices industry, Relisys emerged as one of the key end-to-end solution provider to the Medical Devices industry and as best OEM partner.

With acquisition of Multimedics, Relisys is expanding its business portfolio with CE marked Stent Systems and increasing its footprints globally with entire range of Cardiovascular products besides Coronary Stents. The facility in Baddi for Mutimedics is also aligned with Quality Systems like EN ISO 13485:2016. The CE marked stents are very well distributed across the globe.

Background

The company’s incubation was with a noble idea to make these Cardiovascular Medical Devices available in India at affordable prices that time. Efforts began in a small-scale laboratory for polymer research by few clinicians & technocrats. Dr. APJ Abdul Kalam was also a mentor for these projects for developing these devices indigenously in India.

Inspired by the vision of Dr. Kalam to make medical care affordable, the Company became an independent entity under the name Relisys Medical Devices Limited in 2003. The philosophy behind the project was to design, develop, manufacture and market high quality Medical Devices in Cardiovascular range at most affordable prices thus helping needy patients in India and across the globe. The Company is backed by Technocrats and Medical Specialists. The name Relisys is indicative of Reliable Systems, which will ensure performance, efficacy and safety to the patients. The strategic path is to use innovation and cutting-edge technology besides scale of production to achieve product and pricing advantage over competition.

We at Relisys Medical Devices Limited are committed to:
  • Develop & produce medical devices conforming to International standards that ensure highest safety and claimed efficacy.
  • Ensure delivering of quality products that meet all the requirements of customer and regulatory norms.
  • Continue to conduct professional training at all levels to increase the knowledge and competency of employees.
  • Provide all the resources needed to implement an effective quality management system.
  • Improvement at all stages of operations and strive to be the industry leader.
  • Be rated as the benchmark in all areas of operation

 

Relisys has adopted International Standard, EN ISO 13485:2016 and thus we are committed towards the specified requirements for QMS in order to:
  • Demonstrate its ability to consistently provide and ensure the supply of products manufactured & services provided by Relisys are consistently conforming to customers, applicable standards and prevailing regulatory requirements.
  • Meet customer & regulatory requirements through the effective application of the system, including the processes for improvement of the system and the assurance of conformity to customer and applicable statutory and regulatory requirements.
  • Tighten the Scope of Relisys, for each of the process stages such as Design,Manufacture, Assembling, sterilization, Storage & Dispatch which includes life cycle of a device.

Relisys has adopted International Standard, EN ISO 13485:2016 and thus we are committed towards the specified requirements for QMS in order to:

  • Demonstrateits ability to consistently provide and ensure the supply of products manufactured & services provided by Relisys are consistently conforming to customers, applicable standards and prevailing regulatory requirements.
  • Meet customer & regulatory requirements through the effective application of the system, including the processes for improvement of the system and the assurance of conformity to customer and applicable statutory and regulatory requirements.
  • Tighten the Scope of Relisys, for each of the process stages such as Design, Manufacture, Assembling, sterilization, Storage & Dispatch which includes life cycle of a device.

Research and Development (R&D) refers to the work a business conducts toward the innovation, introduction and improvement of its products and procedures. The R&D Team at Relisys has been working at this goal since the last 10 years. With a stream of products starting from the Bare Metal Stent to various Drug Eluting Stents, the R&D Department has been actively pursuing to develop and introduce new products relevant to our current Cardiovascular field. Currently we are working on Peripheral Stents, Guide Extension and Wedge Pressure Catheter into our ever-expanding portfolio of products. The R&D Department is involved in not just introducing new products but also to constantly improve our existing products, this is done by maintaining a good Post Market Clinical Surveillance to have real-time information about how our products are performing in the market.

Any complaint which arrives is also meticulously analyzed and its root cause determined. Using this data as our base, we work to improve and perfect our devices so that they deliver their optimal performance in the doctor’s hands. For developing or improving any medical device, one of the most important tools to have in hand is to test our devices before they reach the doctor. We at R&D team have developed and implemented certain simulator devices to accurately test our current products and their Improvements at a pre-clinical level to fine tune and perfect them before they reach the end-user. These simulators have been developed and fabricated in-house rather than imported from outside to maintain cost effectiveness in our product development cycle.

With these goals in mind, the R&D team at Relisys seeks to develop new products and improve our existing ones to keep Relisys Medical Devices at the forefront of the market in delivering innovative, effective and cost-effective Medical Devices.